Patent of Flubenzamide Will Expire in the Second Half of 2019

The global sales of flubenzamide listed in 2007 amounted to USD 150 million in 2011; the sales of flubenzamide in 2012 increased further to USD 230 million, with a compound annual growth rate of 87.2% from 2007 to 2012; the global sales of flubenzamide in 2013 increased 93.5% year-on-year, reaching USD 445 million, and the annual growth rate was 77.9% from 2008 to 2013. Brazil is the largest national market for flubenzamide, followed by India, China, the United States and Japan. The patent of flubendiamide will expire on November 29, 2019. At present, the number of domestic flubenzamide products is relatively small in China.
Sign Up For Our E-Newsletter